about
Multifunctional nanoparticles for brain tumor imaging and therapy.Current Trends in Development of Liposomes for Targeting Bacterial BiofilmsNovel formulations for antimicrobial peptidesEmerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systemsLiposomes as nanomedical devicesMicrofluidics-assisted in vitro drug screening and carrier production.Effects of nanoliposomal and pegylated nanoliposomal artemisinin in treatment of breast cancer.Liposomes in tissue engineering and regenerative medicineNovel antigen delivery systems.Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA.Scalable preparation of poly(ethylene glycol)-grafted siRNA-loaded lipid nanoparticles using a commercially available fluidic device and tangential flow filtration.Characterization and stability studies of a novel liposomal cyclosporin A prepared using the supercritical fluid method: comparison with the modified conventional Bangham methodCo-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy.Levofloxacin-proliposomes: opportunities for use in lung tuberculosis.Bioavailability of polyphenol liposomes: a challenge aheadOptimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activityLiposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines.Liposomes and nanotechnology in drug development: focus on neurological targets.Phospholipids at the interface: current trends and challenges.Liposomal antibiotics for the treatment of infectious diseases.Liposomal drug products and recent advances in the synthesis of supercritical fluid-mediated liposomes.Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.Thermosensitive liposomal drug delivery systems: state of the art review.Comparison of Extruded and Sonicated Vesicles for Planar Bilayer Self-Assembly.Phosphatidylserine Lateral Organization Influences the Interaction of Influenza Virus Matrix Protein 1 with Lipid Membranes.Carriers for metal complexes on tumour cells: the effect of cyclodextrins vs CNTs on the model guest phenanthroline-5,6-dione trithiacyclononane ruthenium(II) chloride.Piloting Your Nanovehicle to Overcome Biological Barriers.Liposomal systems as carriers for bioactive compounds.Effect of Chitosan and Liposome Nanoparticles as Adjuvant Codelivery on the Immunoglobulin G Subclass Distribution in a Mouse Model.Artificial Lipid Membranes: Past, Present, and Future.Factors affecting liposomes particle size prepared by ethanol injection method.Deformable liposomes by reverse-phase evaporation method for an enhanced skin delivery of (+)-catechin.Ultrasonic energy in liposome production: process modelling and size calculation.Sonication-Based Basic Protocol for Liposome Synthesis.Therapeutic biomaterials based on extracellular vesicles: classification of bio-engineering and mimetic preparation routes.Development of a novel one-step production system for injectable liposomes under GMP.High-Throughput Continuous Flow Production of Nanoscale Liposomes by Microfluidic Vertical Flow Focusing.The significance of drug-to-lipid ratio to the development of optimized liposomal formulation.Manufacturing Methods for Liposome Adjuvants.Nano- and Microencapsulation of Vitamins
P2860
Q26865418-7E20459F-879D-4ADE-9125-3AF8CD3F6E2DQ26865495-29D8F835-AD80-47D0-92F6-0E9A23810998Q26991771-FD8378EB-F238-452D-A6A8-54EBE344E543Q26996159-72F832D1-BD9A-4264-B828-FA7E2E315318Q28088315-83FBCA29-A7E8-40A0-BE08-2609A0930A0DQ30426039-AA469A02-B936-4CE0-A863-0808FEF6EB80Q34246881-CE9AAE13-B161-477D-AC84-EB4EF95849B2Q34470412-4A637702-1227-47BE-92E7-024C5F27BCE6Q35947894-E36F60D6-3F84-486C-A1AF-5DCED08E74B4Q36234343-6FF61551-6812-4AE6-8088-D2286969A892Q36269077-568EFAE1-8152-4FBD-9768-0F3E1B05E0C6Q36567529-DA1C72C6-D924-4A46-B3F8-F59939042DD8Q37119643-2369A67A-D199-4803-A32A-A8A01814B8B6Q37327834-3CCA06F3-B382-44DA-9F78-A89A9A3FE99BQ37332632-F67A05BB-B19D-4283-808D-5D73BED37BCDQ37434381-A826E082-BE94-44DB-A0B9-EB8964EAFDBDQ38032881-4CC9307A-2058-4F86-8D85-2A827D52A6B2Q38088959-392B13DB-C308-4C64-8BD5-66410F3181B4Q38111970-74452436-AE76-4B7A-AF76-E7595B3A4773Q38124144-3C3689FC-E24B-409D-82FC-119706BB4D0FQ38132414-64F9E758-E3FC-4A7A-A61C-8BD1E32AF173Q38211727-9FA089DA-915A-4C8F-94DD-63178C5474F7Q38254572-435B5C25-FE9E-419A-A35D-BC2A81DD1011Q38623076-01D61300-A81F-4318-A44C-B249E14EBC7BQ38709689-B7864E5E-3C7B-42E8-AD54-7286AC3D6DD8Q39013364-AE143013-6AE5-4B21-BE3E-AD80557886F0Q39114840-DFB5C676-8411-43F2-AB96-0A0C348F2D78Q39310641-87599BD6-F2EB-40D6-84B2-906E67DC48DDQ41056704-1F871F10-95EB-4F3B-8D6E-54976136BEF3Q41666646-AEC7528A-5CBF-4F81-A102-7829DBAA5483Q42112257-6BA96579-2A9B-47F9-AD62-0CC612D262C8Q43483148-ACED2FE7-330D-450A-BF59-1D1F2920D72BQ47178064-ECE92A75-C704-4DB3-BFF9-6CB73B8E8028Q47784038-9A76ED73-69F8-4FD4-9CC8-C16928A0FE48Q48162156-A08692DF-3E02-49E1-AB02-7FCA4AC4F28EQ50954656-C5166B74-9A36-48FF-976A-6DF364F08FD1Q51481558-FD30EFF5-9965-4B5A-B09C-BB8CC5590E27Q53687867-AE2CEDFE-F8AC-4F2A-BD0A-811DBC886307Q54690087-4E88D8C1-BA16-4565-8CC2-E94A639EAC17Q58874329-0BE488F7-FFAD-4237-BC22-DD58275F82C8
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Liposome technology for industrial purposes.
@en
Liposome technology for industrial purposes.
@nl
type
label
Liposome technology for industrial purposes.
@en
Liposome technology for industrial purposes.
@nl
prefLabel
Liposome technology for industrial purposes.
@en
Liposome technology for industrial purposes.
@nl
P2860
P356
P1476
Liposome technology for industrial purposes.
@en
P2093
Andreas Wagner
Karola Vorauer-Uhl
P2860
P304
P356
10.1155/2011/591325
P577
2010-12-05T00:00:00Z